114 related articles for article (PubMed ID: 26665182)
21. The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization.
Koskimaa HM; Paaso A; Welters MJP; Grénman S; Syrjänen K; van der Burg SH; Syrjänen S
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1491-1503. PubMed ID: 28324192
[TBL] [Abstract][Full Text] [Related]
22. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
23. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes.
Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND
Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603
[TBL] [Abstract][Full Text] [Related]
24. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
Hara M; Matsueda S; Tamura M; Takedatsu H; Tanaka M; Kawano K; Mochizuki K; Kamura T; Itoh K; Harada M
Int J Oncol; 2005 Nov; 27(5):1371-9. PubMed ID: 16211234
[TBL] [Abstract][Full Text] [Related]
25. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
26. HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function.
Thomas KJ; Smith KL; Youde SJ; Evans M; Fiander AN; Borysiewicz LK; Man S
Int J Cancer; 2008 Jun; 122(12):2791-9. PubMed ID: 18366058
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
Trimble CL; Piantadosi S; Gravitt P; Ronnett B; Pizer E; Elko A; Wilgus B; Yutzy W; Daniel R; Shah K; Peng S; Hung C; Roden R; Wu TC; Pardoll D
Clin Cancer Res; 2005 Jul; 11(13):4717-23. PubMed ID: 16000566
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia.
Todd RW; Roberts S; Mann CH; Luesley DM; Gallimore PH; Steele JC
Int J Cancer; 2004 Mar; 108(6):857-62. PubMed ID: 14712488
[TBL] [Abstract][Full Text] [Related]
29. Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay.
Kim KH; Greenfield W; Shotts E; Nakagawa M
Clin Vaccine Immunol; 2007 Apr; 14(4):362-8. PubMed ID: 17314231
[TBL] [Abstract][Full Text] [Related]
30. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
31. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
De Bruijn ML; Schuurhuis DH; Vierboom MP; Vermeulen H; de Cock KA; Ooms ME; Ressing ME; Toebes M; Franken KL; Drijfhout JW; Ottenhoff TH; Offringa R; Melief CJ
Cancer Res; 1998 Feb; 58(4):724-31. PubMed ID: 9485027
[TBL] [Abstract][Full Text] [Related]
32. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
33. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
34. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
Meshkat Z; Soleimanjahi H; Mirshahabi H; Meshkat M; Kheirandish M; Hassan ZM
Iran J Immunol; 2011 Jun; 8(2):65-75. PubMed ID: 21705833
[TBL] [Abstract][Full Text] [Related]
35. Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
Korsholm KS; Hansen J; Karlsen K; Filskov J; Mikkelsen M; Lindenstrøm T; Schmidt ST; Andersen P; Christensen D
Vaccine; 2014 Jun; 32(31):3927-35. PubMed ID: 24877765
[TBL] [Abstract][Full Text] [Related]
36. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
37. Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.
Qian J; Dong Y; Pang YY; Ibrahim R; Berzofsky JA; Schiller JT; Khleif SN
Int J Cancer; 2006 Jun; 118(12):3022-9. PubMed ID: 16425257
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of HPV-like particle-activated Langerhans cells in vitro.
Yan L; Woodham AW; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():333-50. PubMed ID: 25348318
[TBL] [Abstract][Full Text] [Related]
39. T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.
Woodham AW; Yan L; Skeate JG; van der Veen D; Brand HH; Wong MK; Da Silva DM; Kast WM
Papillomavirus Res; 2016 Dec; 2():21-30. PubMed ID: 27182559
[TBL] [Abstract][Full Text] [Related]
40. Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.
Agrawal S; Kandimalla ER
Immunooncol Technol; 2019 Oct; 3():15-23. PubMed ID: 35757301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
